Recent advances in targeting coenzyme A biosynthesis and utilization for antimicrobial drug development
- 1 August 2014
- journal article
- review article
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 42 (4) , 1080-1086
Abstract
The biosynthesis and utilization of CoA (coenzyme A), the ubiquitous and essential acyl carrier in all organisms, have long been regarded as excellent targets for the development of new antimicrobial drugs. Moreover, bioinformatics and biochemical studies have highlighted significant differences between several of the bacterial enzyme targets and their human counterparts, indicating that selective inhibition of the former should be possible. Over the past decade, a large amount of structural and mechanistic data has been gathered on CoA metabolism and the CoA biosynthetic enzymes, and this has facilitated the discovery and development of several promising candidate antimicrobial agents. These compounds include both target-specific inhibitors, as well as CoA antimetabolite precursors that can reduce CoA levels and interfere with processes that are dependent on this cofactor. In the present mini-review we provide an overview of the most recent of these studies that, taken together, have also provided chemical validation of CoA biosynthesis and utilization as viable targets for antimicrobial drug development.Keywords
This publication has 50 references indexed in Scilit:
- Combination of Pantothenamides with Vanin Inhibitors as a Novel Antibiotic Strategy against Gram-Positive BacteriaAntimicrobial Agents and Chemotherapy, 2013
- Experimentally Validated Novel Inhibitors of Helicobacter pylori Phosphopantetheine Adenylyltransferase Discovered by Virtual High-Throughput ScreeningPLOS ONE, 2013
- Pantothenamides Are Potent, On-Target Inhibitors of Plasmodium falciparum Growth When Serum Pantetheinase Is InactivatedPLOS ONE, 2013
- The Antibiotic CJ-15,801 Is an Antimetabolite that Hijacks and Then Inhibits CoA BiosynthesisChemistry & Biology, 2012
- Geminal dialkyl derivatives of N-substituted pantothenamides: Synthesis and antibacterial activityBioorganic & Medicinal Chemistry, 2011
- Essentiality and functional analysis of type I and type III pantothenate kinases of Mycobacterium tuberculosisMicrobiology, 2010
- Antibacterial Activity of N -Pentylpantothenamide Is Due to Inhibition of Coenzyme A SynthesisAntimicrobial Agents and Chemotherapy, 2010
- Selective Inhibitors of Bacterial Phosphopantothenoylcysteine SynthetaseJournal of the American Chemical Society, 2009
- Antibiotic evaluation and in vivo analysis of alkynyl Coenzyme A antimetabolites in Escherichia coliBioorganic & Medicinal Chemistry Letters, 2008
- Crystal Structure of a Type III Pantothenate Kinase: Insight into the Mechanism of an Essential Coenzyme A Biosynthetic Enzyme Universally Distributed in BacteriaJournal of Bacteriology, 2006